NCT03962309

Brief Summary

Early identification of individuals at high risk remains the cornerstone of primary cardiovascular prevention (CV). However, cardiovascular screening including people at low CV diseases (CVD) risk are too costly, time consuming and poorly effective in reducing incident CV events to be proposed at population level. Thus, innovative tools that allow to exclude low risk subjects in order to concentrate the relatively poor resources of NHS for primary prevention in high risk groups are needed. In this study, we will assess whether a new low cost strategy for CV risk stratification, based on non-laboratory measures, will allow to recognize low risk subjects who do not need further and expensive measures. To this end, we will take advantage of a General Practitioners (GPs) national network that will allow to work in the natural contest of primary prevention. If successful, the project will provide the basis for future, cost-effective prevention programs to be performed at national level.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,699

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2020

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 24, 2019

Completed
1.6 years until next milestone

Study Start

First participant enrolled

December 18, 2020

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
Last Updated

May 7, 2025

Status Verified

May 1, 2025

Enrollment Period

3.5 years

First QC Date

May 21, 2019

Last Update Submit

May 6, 2025

Conditions

Keywords

ScreeningGeneral PracticeSelf AssessmentAlgorithms for risk stratification

Outcome Measures

Primary Outcomes (1)

  • To develop of a low cost CVD risk score

    The low cost CVD risk score will be developed using variable obtainable only by the self-assessment questionnaire (low-cost) to identify persons at low CVD risk according to Progetto CUORE or SCORE risk estimation.

    1 day

Secondary Outcomes (10)

  • Race

    1 day

  • Marital status

    1 day

  • Education status

    1 day

  • Employment status

    1 day

  • Clinical Family History

    1 day

  • +5 more secondary outcomes

Study Arms (1)

Patients in charge of the participating GPs

In the study will be included patients in charge of the participating GPs aged 40-70 years

Other: Health self-assessment questionnaire

Interventions

The health self-assessment questionnaire includes questions covering anthropometric, sociodemographics, personal and family health history, life style habits and aspects of the behavioral domain. The questionnaire will be administered as paper format or web-based electronic format according to participants' preferences.

Patients in charge of the participating GPs

Eligibility Criteria

Age40 Years - 69 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects aged 40-70 years in charge of GPs, giving the consent to partecipate in the study

You may qualify if:

  • Subjects aged 40-70 years

You may not qualify if:

  • Patients with previous cardiovascular events

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Cooperativa Medici Milano Centro

Milan, Italy

Location

Cooperativa Nucleo Cure Primarie Val Pescara

Pescara, Italy

Location

Cooperativa Medici 2000

Siena, Italy

Location

Study Officials

  • Roberto Latini, MD

    Istituto Di Ricerche Farmacologiche Mario Negri

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2019

First Posted

May 24, 2019

Study Start

December 18, 2020

Primary Completion

June 30, 2024

Study Completion

August 31, 2024

Last Updated

May 7, 2025

Record last verified: 2025-05

Locations